Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey
Burkina Faso, 2017
Get MicrodataCreated on
Dec 05, 2019
Last modified
Dec 05, 2019
Page views
61574
Downloads
49
F7_219_M (f7_219_4)
Data file: f7_jul19
Overview
Valid:
42
Invalid:
0
Type:
Discrete
Start:
580
End:
600
Width:
21
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 00 | 23 |
54.8%
|
|
| 3 | 2 |
4.8%
|
|
| 99 | 1 |
2.4%
|
|
| CCC | 1 |
2.4%
|
|
| Carbocysteine Sirop | 1 |
2.4%
|
|
| Chlore | 1 |
2.4%
|
|
| PARA CP 500MG | 1 |
2.4%
|
|
| Para 500mg | 1 |
2.4%
|
|
| albendazol | 1 |
2.4%
|
|
| amodiaquine | 1 |
2.4%
|
|
| expectoral | 1 |
2.4%
|
|
| hydroxide d'aluminium | 1 |
2.4%
|
|
| mebendazole | 1 |
2.4%
|
|
| meto | 1 |
2.4%
|
|
| meto inj | 1 |
2.4%
|
|
| metoclopramide | 1 |
2.4%
|
|
| phloroglucinol cp | 1 |
2.4%
|
|
| quinine | 1 |
2.4%
|
|
| seringue | 1 |
2.4%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.